Welcome to PanGenX . Our mission is to help people get the most effective medical treatments for their specific individual needs.
Paul is responsible for the development of PanGenX’s software platform including cloud-based services, data integration, semantic web, analytics and visualization technologies. Paul is a serial entrepreneur who has co-founded a number of startups, non-profits, and open source projects based on technologies including semantic web, identity management, privacy, security, electronic communications, and electronic publishing.
Prior to joining PanGenX Paul co-founded Azigo.com a consumer internet service that gives people more control over their relationships with brands. Prior to Azigo he was involved in user-centric identity management. During this period he started the Higgins Personal Data Service project at the Eclipse Foundation, and chaired the Information Card Foundation whose board members included Google, Microsoft, Verizon, Oracle and several others. He consulted for several years to the Office of the Secretary of Defense on command and control technology.
In 2000 Paul was the president of Bitstream/Pageflex, a public company in the electronic publishing space that he co-founded with VC and angel funding in 1985. Prior to this he co-founded Lightspeed Computers a computer aided design company acquired by DuPont in 1985. Paul has a BSEE degree from MIT and was a research assistant at the MIT Media Lab.
Tom is a seasoned life science industry executive. He has an extensive peer-reviewed scientific publication list and has maintained premier collaborative research efforts with both academia and industry throughout his career. He led new diagnostic assay development at Ventana and HTG. At Medtronic, he managed global biotechnology opportunity identification and assessment. His efforts resulting in groundbreaking treatment advances by combining the company’s novel delivery technologies with approved therapeutics.
Prior to Medtronic, Tom was vice president of business development at Lynx Therapeutics, Inc. (later Solexa and eventually acquired by Illumina Inc.). There, he developed and applied next generation DNA sequencing technologies for high speed, whole genome analysis. Tom has also served in various technology and business development roles at Millennium Pharmaceuticals, Corning Advanced Life Science Products, and LabSeek Scientific Collaborative. Through the course of his career, Tom has brokered numerous deals with large therapeutic companies and academic institutions and served as a business and technology consultant for academic and commercial organizations around the world.
Tom received a B.S. degree in chemistry from MIT and a Ph.D. in Genetics from Harvard University, and completed postdoctoral training in developmental biology at Princeton University.